VCIM
KYNB

Velan Capital Investment Management’s Kyntra Bio KYNB Stock Holding History

Velan Capital Investment Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,200
Closed -$42.4K – 52
2024
Q4 		$42.4K Buy
+3,200
New +$29.7K 0.04% 38

Other funds holding KYNB

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Velan Capital Investment Management's KYNB Position: Q1 2025 in Review

Velan Capital Investment Management sold out of Kyntra Bio (KYNB) in Q1 2025, closing a stake of 3,200 shares — an estimated $42.4K sold.

Velan Capital Investment Management first reported a position in KYNB in Q4 2024 and held it in 1 quarter. The position peaked at $42.4K in Q4 2024. 54 funds tracked by Wall St. Rank hold KYNB as of Q1 2025.

  • Velan Capital Investment Management reported no remaining Kyntra Bio position as of Q1 2025 after selling out during the quarter.
  • Velan Capital Investment Management sold 3,200 Kyntra Bio shares in Q1 2025, an estimated $42.4K.
  • Velan Capital Investment Management first reported a position in Kyntra Bio in Q4 2024 and held it in 1 quarter.
  • Velan Capital Investment Management's Kyntra Bio position peaked at $42.4K in Q4 2024.
  • 54 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2025.

Based on Velan Capital Investment Management's 13F filing for Q1 2025, filed 15 May 2025.